GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » 3-Year EPS without NRI Growth Rate

Syngene International (NSE:SYNGENE) 3-Year EPS without NRI Growth Rate : 10.90% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International 3-Year EPS without NRI Growth Rate?

Syngene International's EPS without NRI for the three months ended in Mar. 2024 was ₹4.70.

During the past 12 months, Syngene International's average EPS without NRI Growth Rate was 12.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Syngene International was 62.70% per year. The lowest was 7.40% per year. And the median was 14.15% per year.


Competitive Comparison of Syngene International's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Syngene International's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Syngene International's 3-Year EPS without NRI Growth Rate falls into.



Syngene International 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Syngene International  (NSE:SYNGENE) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Syngene International 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Syngene International's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines